183 related articles for article (PubMed ID: 7693588)
1. High sensitivity to salt in kininogen-deficient brown Norway Katholiek rats.
Majima M; Yoshida O; Mihara H; Muto T; Mizogami S; Kuribayashi Y; Katori M; Oh-ishi S
Hypertension; 1993 Nov; 22(5):705-14. PubMed ID: 7693588
[TBL] [Abstract][Full Text] [Related]
2. Hypertension induced by a nonpressor dose of angiotensin II in kininogen-deficient rats.
Majima M; Mizogami S; Kuribayashi Y; Katori M; Oh-ishi S
Hypertension; 1994 Jul; 24(1):111-9. PubMed ID: 8020999
[TBL] [Abstract][Full Text] [Related]
3. Suppression of rat deoxycorticosterone-salt hypertension by kallikrein-kinin system.
Majima M; Katori M; Hanazuka M; Mizogami S; Nakano T; Nakao Y; Mikami R; Uryu H; Okamura R; Mohsin SS
Hypertension; 1991 Jun; 17(6 Pt 1):806-13. PubMed ID: 1710605
[TBL] [Abstract][Full Text] [Related]
4. An ATP-sensitive potassium channel blocker suppresses sodium-induced hypertension through increased secretion of urinary kallikrein.
Kamata Y; Fujita T; Kato T; Hayashi I; Kurosaka M; Katori M; Fujita Y; Majima M
Hypertens Res; 2009 Mar; 32(3):220-6. PubMed ID: 19262486
[TBL] [Abstract][Full Text] [Related]
5. Essential role of kallikrein-kinin system in suppression of blood pressure rise during the developmental stage of hypertension induced by deoxycorticosterone acetate-salt in rats.
Katori M; Majima M; Mohsin SS; Hanazuka M; Mizogami S; Oh-ishi S
Agents Actions Suppl; 1992; 38 ( Pt 3)():235-42. PubMed ID: 1281379
[TBL] [Abstract][Full Text] [Related]
6. Ebelactone B, an inhibitor of urinary carboxypeptidase Y-like kininase, prevents the development of deoxycorticosterone acetate-salt hypertension in rats.
Majima M; Ikeda Y; Kuribayashi Y; Mizogami S; Katori M; Aoyagi T
Eur J Pharmacol; 1995 Sep; 284(1-2):1-11. PubMed ID: 8549611
[TBL] [Abstract][Full Text] [Related]
7. Role of the renal kallikrein-kinin system in the development of hypertension.
Katori M; Majima M
Immunopharmacology; 1997 Jun; 36(2-3):237-42. PubMed ID: 9228552
[TBL] [Abstract][Full Text] [Related]
8. Differentiation of kinin fractions in ureter urine and bladder urine of normal and kininogen-deficient rats.
Yamasu A; Oh-ishi S; Hayashi I; Hayashi K; Hayashi M; Yamaki K; Nakano T; Sunahara N
J Pharmacobiodyn; 1989 May; 12(5):287-92. PubMed ID: 2681678
[TBL] [Abstract][Full Text] [Related]
9. Demonstration of derivation of rat urinary bradykinin from plasma low-molecular-weight kininogen: a study using kininogen-deficient rats.
Hagiwara Y; Kojima M; Hayashi I; Oh-ishi S
Biochem Biophys Res Commun; 1994 Nov; 204(3):1219-24. PubMed ID: 7980599
[TBL] [Abstract][Full Text] [Related]
10. Crucial suppressive role of renal kallikrein-kinin system in development of salt-sensitive hypertension.
Katori M; Majima M; Hayashi I
Biol Res; 1998; 31(3):143-9. PubMed ID: 9830501
[TBL] [Abstract][Full Text] [Related]
11. Comparative study of endotoxin-induced hypotension in kininogen-deficient rats with that in normal rats.
Ueno A; Ishida H; Oh-ishi S
Br J Pharmacol; 1995 Mar; 114(6):1250-6. PubMed ID: 7620716
[TBL] [Abstract][Full Text] [Related]
12. Increase in vascular sensitivity to angiotensin II and norepinephrine after four-day infusion of 0.3 M sodium chloride in conscious kininogen-deficient brown Norway Katholiek rats.
Majima M; Adachi K; Kuribayashi Y; Mizogami S; Katori M
Jpn J Pharmacol; 1995 Oct; 69(2):149-58. PubMed ID: 8569052
[TBL] [Abstract][Full Text] [Related]
13. Effects of a neutral endopeptidase inhibitor, BP102, on the development of deoxycorticosterone acetate-salt hypertension in kininogen-deficient Brown Norway Katholiek rats.
Nakajima S; Majima M; Ito H; Hayashi I; Yajima Y; Katori M
Int J Tissue React; 1998; 20(2):45-56. PubMed ID: 9638501
[TBL] [Abstract][Full Text] [Related]
14. Oxytocin-induced natriuresis mediated by the renal kallikrein-kinin system in anesthetized male rats.
Adachi K; Majima M; Katori M; Nishijima M
Jpn J Pharmacol; 1995 Mar; 67(3):243-52. PubMed ID: 7630042
[TBL] [Abstract][Full Text] [Related]
15. Functionally active high molecular weight-kininogen was found in the liver, but not in the plasma of brown Norway Katholiek rat.
Hayashi I; Maruhashi J; Oh-ishi S
Thromb Res; 1989 Oct; 56(2):179-89. PubMed ID: 2617467
[TBL] [Abstract][Full Text] [Related]
16. Identification of T-kininogen in high and low molecular weight kininogens deficient rat (brown Norway Katholiek strain).
Hayashi I; Oh-ishi S; Kato H; Enjyoji K; Iwanaga S; Nakano T
Thromb Res; 1985 Aug; 39(3):313-21. PubMed ID: 3850646
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of kinin degradation on the luminal side of renal tubules reduces high blood pressure in deoxycorticosterone acetate salt-treated rats.
Nakajima S; Ito H; Hayashi I; Kuribayashi Y; Okumura T; Yajima Y; Katori M; Majima M
Clin Exp Pharmacol Physiol; 2000; 27(1-2):80-7. PubMed ID: 10696533
[TBL] [Abstract][Full Text] [Related]
18. High-salt diet upregulates kininogen and downregulates tissue kallikrein expression in Dahl-SS and SHR rats.
Wang C; Chao C; Chen LM; Chao L; Chao J
Am J Physiol; 1996 Oct; 271(4 Pt 2):F824-30. PubMed ID: 8898012
[TBL] [Abstract][Full Text] [Related]
19. Role of the renal kallikrein-kinin system in the development of salt-sensitive hypertension.
Katori M; Majima M; Hayashi I; Fujita T; Yamanaka M
Biol Chem; 2001 Jan; 382(1):61-4. PubMed ID: 11258674
[TBL] [Abstract][Full Text] [Related]
20. Effect of Chronic Blockade of the Kallikrein-Kinin System on the Development of Hypertension in Rats.
Rhaleb NE; Yang XP; Nanba M; Shesely EG; Carretero OA
Hypertension; 2001 Jan; 37(1):121-128. PubMed ID: 11208766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
